Clinical Trials Logo

Clinical Trial Summary

Significant pain after shoulder surgery induce worse experience and may delay recovery of patients undergoing shoulder surgery. Interscalene brachial plexus block (ISB) is a common and rapid-onset procedure for pain control of patients undergoing shoulder surgery. However, the high incidence of adverse events such as hemidiaphragmatic paresis, horner syndrome after interscalene block threatened patients' safety and raised clinicians' concerns on them. Hence, effective analgesia alternatives to interscalene block with less complications are needed. Recently, pericapsular Nerve Group (PENG) Block, a new technology is reported for block of articular branches of the shoulder and well pericapsular spread around the glenohumeral joint. In this study, we assume that PENG Block may offer a noinferior analgesia and less incidence of nerve block related adverse events compared with ISB.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05072223
Study type Interventional
Source Henan Provincial People's Hospital
Status Not yet recruiting
Phase N/A
Start date November 1, 2021
Completion date March 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT00497354 - Does a Low Volume Ultrasound-Guided Technique Reduce Common Complications of Interscalene Brachial Plexus Block? Phase 3